デフォルト表紙
市場調査レポート
商品コード
1624004

スマートピル技術の市場規模・シェア・成長分析 (対象領域別、適用疾患別、用途別、エンドユーザー別、地域別):産業予測 (2025~2032年)

Smart Pills Technology Market Size, Share, Growth Analysis, By Target Area (Esophagus, Stomach), By Disease Indication (Barrett's Esophagus, Small Bowel Diseases), By Application, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 264 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
スマートピル技術の市場規模・シェア・成長分析 (対象領域別、適用疾患別、用途別、エンドユーザー別、地域別):産業予測 (2025~2032年)
出版日: 2025年01月03日
発行: SkyQuest
ページ情報: 英文 264 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のスマートピル技術の市場規模は、2023年に39億米ドルと評価され、2024年の42億3,000万米ドルから2032年には81億3,000万米ドルに成長し、予測期間 (2025-2032年) のCAGRは8.5%に達する見通しです。

スマートピルは、デジタルヘルスにおける重要な進歩であり、カプセルのようなデザインと、検出・撮像・標的薬送達などの高度な機能が特徴です。これらの革新的なデバイスは、消化管をナビゲートして、従来は困難であった診断画像を取得し、内視鏡検査のような従来の方法に代わる非侵襲的な代替手段として効果的に機能します。スマートピルは、多くの場合、プロバイダーポータルやモバイルアプリと通信するウェアラブルセンサーパッチと統合され、医療専門家が患者のデータを綿密にモニターできるようになっています。胃不全麻痺や便秘などの消化器疾患の診断を容易にし、服薬アドヒアランスを向上させます。このシステムは、脈拍数、体温、胃pHなどの重要な指標を取得し、患者の健康状態を包括的に把握し、胃腸疾患の診断と管理のアプローチに革命をもたらします。

目次

イントロダクション

  • 分析目的
  • 市場範囲
  • 定義

分析手法

  • 情報調達
  • 二次・一次データの手法
  • 市場規模予測
  • 市場の想定と制約

エグゼクティブサマリー

  • 市場の概要と展望
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と展望

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析

市場の主な考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場魅力度指数 (2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術分析
  • 規制分析
  • 特許分析
  • ケーススタディ

世界のスマートピル技術の市場規模・CAGR:対象領域別 (2025~2032年)

  • 市場概要
  • 食道
  • 小腸
  • 大腸

世界のスマートピル技術の市場規模・CAGR:適用疾患別 (2025~2032年)

  • 市場概要
  • バレット食道
  • 小腸疾患
  • 大腸がん
  • その他

世界のスマートピル技術の市場規模・CAGR:用途別 (2025~2032年)

  • 市場概要
  • カプセル内視鏡
  • ドラッグデリバリー (薬剤送達)
  • 患者モニタリング
  • その他

世界のスマートピル技術の市場規模・CAGR:エンドユーザー別 (2025~2032年)

  • 市場概要
  • 病院・診療所
  • 診断センター
  • 研究センター

世界のスマートピル技術の市場規模・CAGR (2025~2032年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング (2024年)
  • 主要企業が採用した戦略
  • 市場の近年の動向
  • 主要企業の市場シェア (2024年)
  • 主要企業のプロファイル
    • 企業概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較 (2022~2024年)

主要企業のプロファイル

  • IntroMedic Co., Ltd. (韓国)
  • CapsoVision, Inc. (米国)
  • Koninklijke Philips N.V. (オランダ)
  • Olympus Corporation (日本)
  • RF Co., Ltd. (日本)
  • HQ, Inc. (米国)
  • Proteus Digital Health (米国)
  • Medtronic Plc. (アイルランド)
  • Chongqing Jinshan Science & Technology (Group) Co., Ltd. (中国)
  • Check-Cap Ltd. (イスラエル)
  • AnX Robotica Corp. (米国)
  • Shenzhen Jifu Medical Technology Co., Ltd. (中国)
  • etecRx (米国)
  • BodyCap (France)
  • Otsuka America Pharmaceutical, Inc. (米国)
  • GE Healthcare (米国)
  • Boston Scientific Corporation (米国)
  • Given Imaging Ltd. (Now part of Medtronic) (イスラエル)
  • Bio-Images Research Limited (英国)
  • Lucid Diagnostics (米国)

結論と推奨事項

目次
Product Code: SQSG35H2020

Global Smart Pills Technology Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 4.23 billion in 2024 to USD 8.13 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

Smart pills represent a significant advancement in digital health, characterized by their capsule-like design and advanced capabilities such as sensing, imaging, and targeted medication delivery. These innovative devices navigate the gastrointestinal tract to capture diagnostic images that were previously challenging to obtain, effectively serving as non-invasive alternatives to traditional methods like endoscopy. Smart pills often integrate with a wearable sensor patch that communicates with a provider portal and a mobile app, allowing healthcare professionals to closely monitor patient data. They facilitate diagnosis of gastrointestinal conditions, including gastroparesis and constipation, and enhance medication adherence. This system captures vital metrics like pulse rate, body temperature, and gastric pH, offering a comprehensive view of patient health and revolutionizing the approach to diagnosing and managing gastrointestinal disorders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Technology Market Segmental Analysis

Global Smart Pills Technology Market is segmented by Target Area, Disease Indication, Application, End User and region. Based on Target Area, the market is segmented into Esophagus, Stomach, Small Intestine and Large Intestine. Based on Disease Indication, the market is segmented into Barrett's Esophagus, Small Bowel Diseases, Colon Cancer and Others. Based on Application, the market is segmented into Capsule Endoscopy,Drug Delivery,Patient Monitoring and Others. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Technology Market

The global smart pills technology market is poised for substantial growth in the foreseeable future, primarily fueled by the increasing incidence of gastrointestinal disorders, including motility issues, colon cancer, obscure gastrointestinal bleeding, and Crohn's disease. Lifestyle factors such as sedentary habits are also contributing to this rising demand, alongside enhanced patient compliance thanks to minimally invasive techniques associated with smart pills. Furthermore, the market is expected to benefit from the evolving health challenges linked to modern lifestyles. As disposable incomes rise in both developed and emerging markets, more individuals will have the financial means to invest in these innovative technologies. The aging population, particularly those susceptible to inflammatory bowel diseases like ulcerative colitis and Crohn's disease, will also serve as a significant driver for market expansion.

Restraints in the Global Smart Pills Technology Market

The Global Smart Pills Technology market faces several constraints that hinder its growth despite the numerous benefits offered by this innovative technology. Key challenges include the limited technological advancement of capsule endoscopes and patients' concerns regarding the ingestion of microchips. Moreover, the high prices associated with ingestible sensors, combined with stringent government regulations governing their usage, further restrict market expansion. In developing countries, inadequate reimbursement policies often result in insufficient patient coverage, exacerbating the issue. Additionally, the technological shortcomings of various smart pill applications impede their widespread adoption throughout the forecast period, posing significant barriers to market progress.

Market Trends of the Global Smart Pills Technology Market

The Global Smart Pills Technology market is experiencing significant growth, driven by the increasing demand for innovative, AI-IoT solutions like the Smart Pill Expert System (SPES). As healthcare systems face challenges such as Medical Non-Adherence (MNA), SPES provides a reliable platform for automating medication administration and enhancing patient monitoring in nursing homes, hospices, and home healthcare facilities. Its ability to serve multiple users simultaneously while maintaining a low failure rate underscores its potential to improve medication adherence and patient outcomes. Additionally, the integration of advanced chatbots for real-time health assessments further distinguishes SPES, positioning it as a frontrunner in the evolving healthcare landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Regulatory Analysis
  • Patent Analysis
  • Case Studies

Global Smart Pills Technology Market Size by Target Area & CAGR (2025-2032)

  • Market Overview
  • Esophagus
  • Stomach
  • Small Intestine
  • Large Intestine

Global Smart Pills Technology Market Size by Disease Indication & CAGR (2025-2032)

  • Market Overview
  • Barrett'S Esophagus
  • Small Bowel Diseases
  • Colon Cancer
  • Others

Global Smart Pills Technology Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring
  • Others

Global Smart Pills Technology Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals and Clinics
  • Diagnostic Centres
  • Research Centres

Global Smart Pills Technology Market Size & CAGR (2025-2032)

  • North America (Target Area, Disease Indication, Application, End User)
    • US
    • Canada
  • Europe (Target Area, Disease Indication, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Target Area, Disease Indication, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Target Area, Disease Indication, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Target Area, Disease Indication, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • IntroMedic Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CapsoVision, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RF Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HQ, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteus Digital Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic Plc. (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chongqing Jinshan Science & Technology (Group) Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Check-Cap Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AnX Robotica Corp. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shenzhen Jifu Medical Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • etecRx (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BodyCap (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Otsuka America Pharmaceutical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Given Imaging Ltd. (Now part of Medtronic) (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Images Research Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lucid Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations